Source: Clive Maund 10/25/2022 Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's...
The royalties cost more than the sales coming in. The post Silo Wellness Kills Marley Deal Over Slow Sales appeared first on Green Market Report.
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6, WKN:A3CSSU) is pleased to announce, as a follow up to the Company’s press release dated...
More groups are researching the effect of psychedelics on TBI. The post Doctors Look to Psychedelics to Address Concussion Crisis appeared first on Green...
The article Algernon Partners with Yale University for DMT Phase 2 Depression Trial was originally published on Microdose. For more information on Algernon...
Canadian clinical stage drug development company, Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF), has entered an investigator-initiated clinical...
Core One Labs Inc. (CSE: COOL | OTC: CLABF | Frankfurt: LD6, WKN: A3CSSU), further to its press release dated August 18, 2022, is excited to announce...
Core One Labs Inc. (CSE: COOL | OTC: CLABF | Frankfurt: LD6, WKN: A3CSSU), is pleased to announce that it is nearing good manufacturing practices (GMP)...
Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN)), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to provide...
New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients The post Alberta pioneers psychedelic...